BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23798598)

  • 1. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats.
    Mochida T; Hira T; Hara H
    Endocrinology; 2010 Jul; 151(7):3095-104. PubMed ID: 20410194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.
    Hira T; Mochida T; Miyashita K; Hara H
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G663-71. PubMed ID: 19661152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats.
    Kato M; Nakanishi T; Tani T; Tsuda T
    Nutr Res; 2017 Jan; 37():37-45. PubMed ID: 28215313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
    Xu Z; Ju J; Wang K; Gu C; Feng Y
    J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion.
    Cani PD; Holst JJ; Drucker DJ; Delzenne NM; Thorens B; Burcelin R; Knauf C
    Mol Cell Endocrinol; 2007 Sep; 276(1-2):18-23. PubMed ID: 17681422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
    Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L
    Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.
    Alssema M; Rijkelijkhuizen JM; Holst JJ; Teerlink T; Scheffer PG; Eekhoff EM; Gastaldelli A; Mari A; Hart LM; Nijpels G; Dekker JM
    Eur J Endocrinol; 2013 Oct; 169(4):421-30. PubMed ID: 23864340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
    Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
    Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; Golor G; Schrodter A; Keymeulen B; Lasseter KC; Kipnes MS; Snyder K; Hilliard D; Tanen M; Cilissen C; De Smet M; de Lepeleire I; Van Dyck K; Wang AQ; Zeng W; Davies MJ; Tanaka W; Holst JJ; Deacon CF; Gottesdiener KM; Wagner JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4612-9. PubMed ID: 16912128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice.
    Ahrén B; Yamada Y; Seino Y
    Front Endocrinol (Lausanne); 2021; 12():665537. PubMed ID: 34122340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
    Bhat VK; Kerr BD; Flatt PR; Gault VA
    Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
    Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Yokoyama H; Haneda M
    Front Endocrinol (Lausanne); 2020; 11():214. PubMed ID: 32390941
    [No Abstract]   [Full Text] [Related]  

  • 20. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.